Onderneming Shanghai Kaibao Pharmaceutical CO.,Ltd
Aandelen
300039
CNE100000JZ3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,16 CNY | +0,82% | +2,16% | -7,37% |
Vakgebied
Aantal werknemers: 1 380
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Injection
88,5
%
| 935 | 83,5 % | 1 410 | 88,5 % | +50,87% |
Capsules
10,0
%
| 159 | 14,2 % | 160 | 10,0 % | +0,58% |
Tablets
1,2
%
| 19 | 1,7 % | 19 | 1,2 % | +0,03% |
Other Medicines
0,2
%
| 5 | 0,4 % | 2 | 0,2 % | -44,90% |
Other
0,1
%
| 1 | 0,1 % | 2 | 0,1 % | +95,91% |
Rental
0,1
%
| 1 | 0,1 % | 1 | 0,1 % | -23,19% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 119 | 100,0 % | 1 594 | 100,0 % | +42,47% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ying Bin Zhou
CEO | Chief Executive Officer | 46 | 10-11-17 |
Dong Sheng Xue
CHM | Chairman | 54 | - |
Li Wang Ren
DFI | Director of Finance/CFO | 54 | 25-10-18 |
Jing Wei Mu
CHM | Chairman | 45 | - |
Ning Bo Zhao
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-01-05 |
Fa Kai Lu
BRD | Director/Board Member | 37 | - |
Ke Ji Zhao
BRD | Director/Board Member | 41 | - |
Cong Ying Ma
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jing Wei Mu
CHM | Chairman | 45 | - |
Li Wang Ren
DFI | Director of Finance/CFO | 54 | 25-10-18 |
Zu Guang Ye
BRD | Director/Board Member | 77 | 10-12-20 |
Dong Sheng Xue
CHM | Chairman | 54 | - |
Ning Bo Zhao
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-01-05 |
Ying Bin Zhou
CEO | Chief Executive Officer | 46 | 10-11-17 |
Ke Ji Zhao
BRD | Director/Board Member | 41 | - |
Zhen Ni Li
BRD | Director/Board Member | 49 | 10-12-20 |
Fa Kai Lu
BRD | Director/Board Member | 37 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 046 000 000 | 557 926 487 ( 53,34 %) | 0 | 53,34 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
19 002 728 | 16.39% | 112 689 408 $ |
Bedrijfsgegevens
Shanghai Kaibao Pharmaceutical Co., Ltd.
88 Chengpu Road Comprehensive Industrial Dev Zone
201401, Shanghai
+
http://www.xykb.comSector
Verkoop per activiteit
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,37% | 890 mln. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |
- Beurs
- Aandelen
- Koers 300039
- Onderneming Shanghai Kaibao Pharmaceutical CO.,Ltd